Julie Diana Smith - 01 Jan 2022 Form 3 Insider Report for MERIDIAN BIOSCIENCE INC

Role: Sr VP, Controller, PAO
Signature: /s/ F. Mark Reuter as Attorney-in-Fact for Julie Diana Smith
Issuer symbol: N/A
Transactions as of: 01 Jan 2022
Net transactions value: $0
Form type: 3
Filing time: 03 Jan 2022, 08:08:24 UTC
Next filing: 05 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	VIVO	Common Stock						25,600	01 Jan 2022	By Spouse
holding	VIVO	Common Stock						33,036	01 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	VIVO	Option to Buy							01 Jan 2022	Common Stock	2,000	$6.97	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Includes restricted share units granted pursuant to the Issuer's shareholder approved equity compensation plan as follows: 1,200 RSUs vesting on 9/16/22; 6,160 RSUs vesting on 11/15/22; 5,411 RSUs vesting on 11/15/23; 5,297 RSUs vesting pro rata over four years beginning 11/4/22; 5,000 RSUs vesting pro rata over four years beginning 12/6/22.